Skip to main content

1-20 of 357 results for subject:Embryos

Type

House

Session

Year

Department

Member

More

Primary member

Answering member

Legislative stage

Legislation

Subject

More

Publisher


Show detailed: On Off
Results: 10 20 50 100
Sort by: Newest first Oldest first

Lords motion to take note of the adequacy of the law on the regulation of fertility treatment. Agreed to on question.

Lead member
Baroness Deech
Answering member
Baroness Blake of Leeds
Department
Department of Health and Social Care
Type
Debates
Date
4 June 2026
Reference
856 cc944-973
House
House of Lords

My Lords, I declare an interest as a former chairwoman of the HFEA. When I was approached for the job, I explained that, at my school, we were not even taught what were then called the “facts of life”. It turned out that this did not matter, as the task...

Member
Baroness Deech (Crossbench)
Type
Proceeding contributions
Date
4 June 2026
Reference
856 cc945-8
House
House of Lords

My Lords, I thank the noble Baroness, Lady Deech, for bringing this matter to the House. At present, the HFEA regulations are under a law that is over 35 years old, as identified by the noble Baroness, Lady Deech, and the legislation is unfit for the purpose in many areas....

Member
Lord Palmer of Childs Hill (Liberal Democrat)
Type
Proceeding contributions
Date
4 June 2026
Reference
856 cc946-9
House
House of Lords

My Lords, I would like to come down to earth a little bit. First of all, I suggest that infertility is not a disease; it is actually a symptom of something wrong, and that is the basic problem here. What we are doing here with in vitro fertilisation is using...

Member
Lord Winston (Labour)
Type
Proceeding contributions
Date
4 June 2026
Reference
856 cc949-951
House
House of Lords

My Lords, it is a privilege to follow the noble Lord, Lord Winston. We live in an increasingly digital world. We entrust apps with our fitness data and menstrual cycle, and healthcare providers frequently offer virtual consultations. It is no surprise, therefore, that many people entrust fertility treatment to the...

Member
Baroness Owen of Alderley Edge (Conservative)
Type
Proceeding contributions
Date
4 June 2026
Reference
856 cc951-3
House
House of Lords

My Lords, I recognise the depth of expertise in this Chamber and that my background is not a scientific one. However, it is incumbent on us all to engage in these crucial issues, which hold wide significance and implication. I approach this debate in the knowledge of what it is...

Member
Bishop of Chelmsford (Bishops (affiliation); Bishops (affiliation); Bishops (affiliation); Bishops (affiliation))
Type
Proceeding contributions
Date
4 June 2026
Reference
856 cc953-5
House
House of Lords

My Lords, it is a great pleasure to follow the right reverend Prelate. That was very moving, and I am very pleased that her three children are in this world thanks to the noble Lord, Lord Winston. That is amazing. Like the noble Baroness, Lady Deech, I confess my inner...

Member
Baroness Boycott (Crossbench)
Type
Proceeding contributions
Date
4 June 2026
Reference
856 cc955-6
House
House of Lords

My Lords, it is a pleasure to follow the noble Baroness, Lady Boycott. I thank the noble Baroness, Lady Deech, for securing this very important debate. I declare an interest as a board

member of the Human Fertilisation and Embryology Authority and as someone who previously led IVF and fertility...

Member
Baroness Nargund (Labour)
Type
Proceeding contributions
Date
4 June 2026
Reference
856 cc956-8
House
House of Lords

My Lords, I pay tribute to the noble Baroness, Lady Deech, for securing this important debate. Before I start, I will just clarify one issue: about 98% of abortion treatment is carried out in the not-for-profit sector, funded around 98% by the NHS. NHS hospitals do not make a profit...

Member
Baroness Gerada (Crossbench)
Type
Proceeding contributions
Date
4 June 2026
Reference
856 cc958-960
House
House of Lords

My Lords, I am grateful to the noble Baroness, Lady Deech, for bringing these important questions to the House. Women’s health, fertility, and experience of motherhood are matters that are rarely given the attention they deserve, and I am hugely grateful for the opportunity to learn from the expertise of...

Member
Baroness Shawcross-Wolfson (Conservative)
Type
Proceeding contributions
Date
4 June 2026
Reference
856 cc960-2
House
House of Lords

My Lords, I thank the noble Baroness, Lady Deech, for bringing forward this important short debate and for her work in this area. I am also grateful for the richness of the debate from noble Lords across the House, and with such expertise, and for the personal contribution from right...

Member
Baroness Pidgeon (Liberal Democrat)
Type
Proceeding contributions
Date
4 June 2026
Reference
856 cc962-5
House
House of Lords

My Lords, I thank the noble Baroness, Lady Deech, for her focus on this subject, drawing on her extensive experience in the sector, including chairing the Human Fertilisation and Embryology Authority for eight years. I also highlight the deep knowledge of the noble Baroness, Lady Nargund, who combines her role...

Member
Earl of Effingham (Conservative; Crossbench)
Type
Proceeding contributions
Date
4 June 2026
Reference
856 cc965-7
House
House of Lords

My Lords, I am very pleased to respond to this debate, particularly regarding the adequacy of law on the regulation of fertility treatment. I thank the noble Baroness, Lady Deech, for raising this topical and important matter and for her thoughtful and wide-reaching comments which framed the debate that followed.

As...

Member
Baroness Blake of Leeds (Labour)
Type
Proceeding contributions
Date
4 June 2026
Reference
856 cc967-971
House
House of Lords

Before the Minister sits down, I wonder whether she would be kind enough to answer one question for me. The figures that I presented on embryo freezing show that there were 909 births, some of which miscarried. However, it is clear that at least 42,000 treatments with embryos were given...

Member
Lord Winston (Labour)
Type
Proceeding contributions
Date
4 June 2026
Reference
856 c971
House
House of Lords

I am delighted to say that I will pass on my noble friend’s comments to the noble Baroness, Lady Merron. As I said, she will follow up on further comments that he has made today. I was struck by the statistics that I looked at and that my noble friend...

Member
Baroness Blake of Leeds (Labour)
Type
Proceeding contributions
Date
4 June 2026
Reference
856 cc971-2
House
House of Lords

My Lords, this debate has consisted of highs and lows. One high, of course, is that it is wonderful that the House of Lords has so many world experts on infertility ready to speak today and contribute their knowledge. That is what we are all about. The lows I am...

Member
Baroness Deech (Crossbench)
Type
Proceeding contributions
Date
4 June 2026
Reference
856 cc972-3
House
House of Lords

My Lords, Nestlé and Danone launched product recalls of certain infant formula products because of the possible presence of cereulide toxin. This is a live incidence and it is too early to identify any systemic issues.

The Food Standards Agency is working across agencies and with the Department of Health and Social Care to manage the incident response. The FSA has published information on the product recalls on its website, including advice for consumers.

Answered by
Baroness Merron (Labour)
Type
Oral answers to questions
Date
4 February 2026
Reference
852 c1603
House
House of Lords

I thank the Minister for her Answer, but I would posit that there is very clearly a well-identified systemic problem that non-mandatory ingredients such as arachidonic acid, which is the source of the current contamination in Nestlé and Danone products, place a burden on infant metabolism and create multiple potential points of microbial and other contamination in the manufacturing process by the four companies that supply the vast bulk of infant formula in this country through complex, for-profit global supply chains. Are the Government going to look into further action on this?

Asked by
Baroness Bennett of Manor Castle (Green Party)
Oral questions - 1st Supplementary
Status
Answered
Date
4 February 2026
Reference
852 c1603
House
House of Lords

Obviously, we are very concerned about toxins and ensuring that there is no damage done to people: that is the reason for the product recall. The effect of this is that it creates bacteria, so it is like food poisoning in that respect.

With regard to what the noble Baroness has said about ARA oil, the concern of the FSA is very much about safety. What has happened here, as I understand, is that ARA oil is a very common ingredient, but this one appears to have had some contamination, which has affected certain batches, and it is those that are being recalled.

Answered by
Baroness Merron (Labour)
Type
Oral answers to questions
Date
4 February 2026
Reference
852 c1603
House
House of Lords

My Lords, what the Minister said is correct, but only partially. Arachidonic acid is the key component that may contain bacillus cereus, which is the product that produces the toxin cereulide, which causes problems for babies including vomiting and

diarrhoea. It is the same as any bacteria or virus that causes the gut rot that we often experience. It is a supply chain problem and the current regulatory mechanism relies on self-regulation. That is what needs to be addressed. We had a similar problem in 2008 with another chemical called melamine, which was in milk products and caused kidney damage to babies. Does the Minister agree that it is the regulation of the supply chain and production that needs to be addressed?

Asked by
Lord Patel (Crossbench)
Oral questions - Supplementary
Status
Answered
Date
4 February 2026
Reference
852 c1603
House
House of Lords